fda changes semaglutide compounding news issues warning about some compounded versions of for diabetes, weight loss Important Update: to Compounded FDA's Removal of Semaglutide and

Midi has been mind-blowing

The major anti-obesity mode of action of semaglutide and tirzepatide is increasing satiety by regulating the activity of appetite-sensing neurocircuits at the level of the brain stem and hypothalamus

Blankenberg, S., Barbaux, S

From a theoretical perspective this is plausible because the same brain areas that regulate appetite and food satiety are also implicated in appetitive desire to consume alcohol and other drugs consumption of both food and alcohol/drugs are considered appetitive behaviors

Most people don't realize how many hundreds of metabolic functions in our bodies require minerals

Neuron 52, 3959